
Braiin Ltd (NASDAQ:BRAI – Free Report) – Investment analysts at Maxim Group issued their FY2026 earnings per share (EPS) estimates for Braiin in a research report issued on Monday, June 15th. Maxim Group analyst A. Klee anticipates that the company will post earnings per share of ($0.02) for the year. Maxim Group currently has a “Buy” rating and a $10.00 price target on the stock. Maxim Group also issued estimates for Braiin’s FY2027 earnings at $0.01 EPS and FY2028 earnings at $0.05 EPS.
Other analysts have also issued research reports about the stock. Weiss Ratings started coverage on shares of Braiin in a research report on Wednesday, May 6th. They set a “sell (e+)” rating on the stock. Wall Street Zen upgraded Braiin from a “sell” rating to a “hold” rating in a report on Sunday, May 31st. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $10.00.
Braiin Price Performance
Shares of BRAI stock opened at $7.49 on Wednesday. The company has a 50-day moving average price of $7.83. Braiin has a twelve month low of $4.19 and a twelve month high of $33.00.
Key Braiin News
Here are the key news stories impacting Braiin this week:
- Positive Sentiment: Maxim Group initiated coverage on Braiin Ltd with a buy rating and a $10.00 price target, signaling potential upside and likely boosting investor confidence. Braiin is now covered by Maxim Group. They set a “buy” rating and a $10.00 price target on the stock. This represents a 33.5% upside from the current price of $7.49. Read More: Benzinga, The Fly, Zacks.com
- Neutral Sentiment: The rest of the recent items are general brain-health and neuroscience articles, including topics like brain implants, memory, and brain aging. These are not directly tied to Braiin Ltd’s business or financial results, so they are unlikely to be a major driver of the stock today.
Braiin Company Profile
Braiin Limited is an Australian technology company leveraging proprietary intellectual property and patented artificial intelligence/machine learning (“AI/ML”) technologies to deliver actionable insights across high-growth verticals: Agriculture, Property Technology, and Customer Experience as a Service (“CXaaS”). Our platforms are designed to address inefficiencies and drive data-backed decision-making across traditionally analog sectors. Our first commercial focus is on the agriculture technology sector, where we have successfully deployed our AI-powered solutions across multiple implementations.
Recommended Stories
- Five stocks we like better than Braiin
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Receive News & Ratings for Braiin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Braiin and related companies with MarketBeat.com's FREE daily email newsletter.
